原发性脑肿瘤放疗患者抑郁焦虑症状与神经认知功能的纵向关联分析
本研究对54例接受放疗的原发性脑肿瘤患者进行前瞻性纵向分析,在放疗前及放疗后3、6、12个月评估抑郁焦虑症状与领域特异性神经认知功能。多变量线性混合效应模型显示,焦虑症状升高与注意力/处理速度变差独立相关,抑郁症状升高也与注意力/处理速度变差相关;抑郁焦虑症状应在临床试验中控制并在临床中管理以优化神经认知功能。
要点
- 焦虑评分越高与注意力/处理速度越差独立相关(多变量分析均P≤.01)。
- 抑郁评分越高与注意力/处理速度越差相关(多变量P=.013)。
- 抑郁焦虑症状应在临床试验中控制并临床管理以优化神经认知。
核心结论
- 在接受放疗的原发性脑肿瘤患者中,抑郁和焦虑症状加重与神经认知功能变差独立相关,尤其表现在注意力/处理速度领域。
研究设计与样本
- 前瞻性纵向分析纳入54例接受放疗的原发性脑肿瘤患者,在基线(放疗前)及放疗后3、6、12个月进行综合神经认知评估和抑郁焦虑评估。
- 使用Beck抑郁量表第二版(BDI-II)和Beck焦虑量表(BAI)评估症状,采用单变量和多变量线性混合效应模型分析关联,控制既往抑郁或焦虑障碍及患者、肿瘤和治疗特征。
主要发现
- BAI评分越高与DKEFS-TMT视觉扫描(P=.003)、数字排序(P=.011)和字母排序(P<.001)反映的注意力/处理速度越差相关,多变量分析中这些关联仍显著(均P≤.01)。
- BDI-II评分越高与DKEFS-TMT字母排序反映的注意力/处理速度越差相关(单变量P=.002,多变量P=.013)。
- BAI评分越高与Brief Visuospatial Memory Test-Revised延迟回忆反映的视空间记忆越差相关仅见于单变量分析(P=.012),多变量分析不显著(P=.383)。
- BDI-II评分越高与DKEFS Verbal Fluency类别切换反映的执行功能越差相关仅见于单变量分析(P=.031),多变量分析不显著(P=.198)。
临床怎么用
- 对接受放疗的原发性脑肿瘤患者应评估和管理抑郁焦虑症状,以优化神经认知功能。
- 在前瞻性临床试验中应将抑郁焦虑症状作为控制变量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Primary brain tumor patients are vulnerable to depression and anxiety symptoms, which may affect their neurocognitive functioning. We performed a prospective longitudinal analysis to examine the association between depression and anxiety symptoms and domain-specific neurocognitive functioning in primary brain tumor patients receiving radiation therapy (RT). METHODS AND MATERIALS: On a prospective trial, 54 primary brain tumor patients receiving RT underwent comprehensive neurocognitive evaluation at baseline (pre-RT), and 3, 6, and 12 months post-RT. Neurocognitive assessments measured attention/processing speed, verbal and visuospatial memory, and executive functioning, including Delis-Kaplan Executive Function System Trail-Making Test (DKEFS-TMT), DKEFS Verbal Fluency, and Brief Visuospatial Memory Test-Revised. Depression and anxiety symptoms were also assessed at each time point with Beck Depression and Anxiety Inventories (BDI-II and BAI), respectively. Higher scores reflect more numerous or severe depression or anxiety symptoms. Univariable and multivariable linear mixed-effects models assessed associations between BDI-II and BAI scores and domain-specific neurocognitive scores over time, controlling for pre-existing depression or anxiety disorders and other patient, tumor, and treatment characteristics. RESULTS: Higher BAI scores were associated with worse attention and processing speed in univariable analyses: DKEFS-TMT visual scanning (P = .003), number sequencing (P = .011), and letter sequencing (P <.001). On multivariable analyses, these associations remained significant (all P ≤ .01). Higher BDI-II scores were also associated with poorer attention/processing speed (DKEFS-TMT Letter Sequencing) in univariable (P = .002) and multivariable (P = .013) models. Higher BAI scores were associated with worse visuospatial memory (Brief Visuospatial Memory Test-Revised Delayed Recall) on univariable (P = .012) but not multivariable analyses (P = .383). Similarly, higher BDI-II scores were associated with poorer executive functioning (DKEFS Verbal Fluency Category Switching) on univariable (P = .031) but not multivariable analyses (P = .198). CONCLUSIONS: Among primary brain tumor patients receiving RT, increased depression and anxiety were independently associated with worsened neurocognition, particularly in attention/processing speed. Depression and anxiety symptoms should be controlled for in prospective clinical trials and managed in the clinical setting to optimize neurocognitive functioning.
引用
- Tibbs MD, Huynh-Le MP, Reyes A, et al. Longitudinal Analysis of Depression and Anxiety Symptoms as Independent Predictors of Neurocognitive Function in Primary Brain Tumor Patients. Int J Radiat Oncol Biol Phys. 2020. PMID: 32634542. doi:10.1016/j.ijrobp.2020.07.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。